Female Reproductive Life Cycle and Hormones: Methodology to Improve Clinical Trials

Marlene P. Freeman, MD; Rosemary Walker, BA; Thomas P. Laughren, MD; Karen K. Miller ,MD; and Maurizio Fava, MD

Because this piece does not have an abstract, wehave provided for your benefit the first 3 sentences of the fulltext.

 

In clinical trials, there are 2 competing ethical priorities regarding the participation of women. One is that women of childbearing potential could become pregnant during a trial, raising concern over fetal exposure to an agent of unknown reproductive safety. The other is the need for development of treatments specific to subpopulations of patients in order to better inform care.

J Clin Psychiatry 2013;74(10):1018-1021

https://doi.org/10.4088/JCP.13com08742

© Copyright 2013 Physicians Postgraduate Press, Inc.